• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down 1.54% Nasdaq Down 1.52%

    Alexza Pharmaceuticals Inc. (ALXA)

    -NasdaqCM
    2.07 Up 0.10(5.08%) Apr 17, 4:00PM EDT
    Add to Portfolio
    Prev Close:1.97
    Open:1.98
    Bid:1.81 x 200
    Ask:2.07 x 100
    1y Target Est:6.25
    Beta:0.46
    Next Earnings Date: 6-May-15ALXA Earnings announcement
    Day's Range:1.92 - 2.08
    52wk Range:1.25 - 5.27
    Volume:32,819
    Avg Vol (3m):44,889
    Market Cap:40.17M
    P/E (ttm):N/A
    EPS (ttm):-2.07
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for ALXA

    Comparison

    Symbol% ChgMkt Cap
    ALXAUp 5.08%40.17M
    ALKSDown 1.40%9.30B
    ARDMDown 0.30%97.93M
    LLYDown 1.39%76.86B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):6.87
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :-1.93
    Quarterly EPS Est (Mar-15) :-0.51
    Mean Recommendation*:2.0
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Alexza Pharmaceuticals, Inc., a pharmaceutical company, focuses on the research, development, and commercialization of proprietary products for the acute treatment of central nervous system conditions worldwide. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback